Consider a history of chronic pain, anxiety, or widespread pain when you schedule treatment
Specific cardiac considerations include: Heart rhythm concerns: The heart rate-increasing effect may require additional monitoring in patients with atrial fibrillation, supraventricular tachycardia, or ventricular arrhythmias Heart failure: Patients with New York Heart Association (NYHA) Class III-IV heart failure were excluded from major clinical trials, and there is limited safety data in this population [18] [21] Recent cardiac events: Patients with recent myocardial infarction, stroke, or unstable angina may require individualized assessment during the recovery period Hemodynamic considerations: Rapid weight loss may affect fluid balance in patients with significant cardiac disease Adverse effects relevant to cardiac patients include gastrointestinal symptoms (nausea, vomiting, diarrhea) that may lead to dehydration and electrolyte disturbances
Use With Caution / Additional Monitoring in Research Contexts Because Ipamorelin is researched for its interaction with growth hormone and IGF-1 signaling pathways, caution is advised in research models involving endocrine, metabolic, cardiovascular, or proliferative conditions
The meaningful differences come down to how they work and how well a given person tolerates them
These are very valid concerns
Acute Kidney Injury (AKI)
